Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

U.S. Legislative Update: Takeaways for European Pharma (European Pharmaceutical Review)

Related Content

Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference

Updated AAA Rules and Fees Could Change the Mass Arbitration Landscape

What’s Next for AI? Six Areas to Watch in 2024

Sixth Circuit Does Not Permit Third-Party Releases in Equity Receiverships

Second Circuit Upholds Dismissal of AstraZeneca Investor Suit

Court Dismisses Post-SPAC Class Action for Lack of Standing

SEC Brings Suit Against Owner of BitTorrent, Inc., and Settles Claims With Celebrity Endorsers of Certain Crypto Tokens

Privilege: The US Perspective (Global Investigation Review’s Practitioner’s Guide to Global Investigations

ACI's 19th FCPA & Anti-Corruption for the Life Sciences Industry

Abingworth to Provide Teva with up to $150 Million in Financing to Advance Treatment of Asthma

Goodwin Welcomes Prominent Litigation Partner Patrick Gunn in San Francisco

Goodwin Prevails on Behalf of Immigration Petitioner at U.S. Supreme Court in Wilkinson v. Garland

Leading PTAB Partner Lori Gordon Joins Goodwin’s Intellectual Property Litigation Practice in Washington, DC

NAPCO Securities Technologies Completes $81.5 Million Secondary Offering

Once Again, Goodwin Is The Top Firm for Global M&A

Goodwin Represents the Initial Purchasers and Dealers on Lyft, Inc.’s $460 million 0.625% Convertible Senior Notes Offering and Capped Call

Life Sciences

Litigation

Intellectual Property